The clinical significance of the fastidious organism DF-3 isolated from stool cultures is unclear. We sought to improve our understanding of this organism and to further define its association with human disease. Stool cultures for DF-3 were obtained from three sources: an ongoing study of enteric pathogens in patients infected with the human immunodeficiency virus, a screening procedure in which all stool samples submitted for Clostridium difficile toxin assay were cultured for DF-3, and stool samples submitted specifically for DF-3 culture. Retrospective clinical data were obtained from chart reviews of patients with positive cultures. Antimicrobial susceptibility testing and cell wall fatty acid analysis were performed for each DF-3 isolated.
by using selective media. The presence of 12-methyltetradecanoate in cell wall fatty acid analysis assists in identification. The increased use of a selective medium-(cefoperazone-vancomycin-amphotericin B) in the evaluation of diarrhea in immunocompromised hosts, including persons with inflammatory bowel disease, may better define the association of DF-3 with human gastrointestinal disease. DF-3 is the designation given by the Special Bacterial Pathogens Laboratory of the Centers for Disease Control for a fastidious, small, coccobacillary gram-negative organism (4) . Wagner et al. (12) reported on 53 DF-3 isolates from a variety of sources that been referred to the Centers for Disease Control through 1987; 10 of the isolates had been recovered from blood cultures. The organism has been associated with human disease, including soft-tissue infection (2) , bacteremia (1) , and diarrhea (12) . The role of this organism as a cause of diarrhea has been suggested by Wagner et al. (12) , although the mechanisms remain unclear.
DF-3 does not grow well on standard enteric isolation media such as MacConkey, Salmonella Shigella, xyloselysine-deoxycholate agars or most selective Campylobacter media incubated at 42°C. It is best recovered from stool specimens through the use of selective culture media containing antimicrobial agents, such as cefoperazone and van- comycin, that inhibit the overgrowth of normal stool flora. An example of this medium is cefoperazone-vancomycinamphotericin (Remel Laboratories, Lenexa, Kans.) blood agar incubated at 35°C. Thus, the organism will not be recovered from routine stool cultures in most laboratories unless a specific search is made.
The agents of diarrhea in immunocompromised patients include common bacterial pathogens, mycobacteria, protozoa, fungi, and viruses (3, 11, 14) , although a definable * Corresponding author.
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etiology is present in only 60% of cases (10) . The linkage between DF-3 and diarrhea in the few reported cases is based on clinical recovery following antimicrobial therapy and elimination of the organism from follow-up stool specimens. We sought to improve our understanding of the role of DF-3 in diarrheal disease by prospective screening of stool samples submitted for culture. As a result, we report eight cases of enteric DF-3 in immunocompromised patients. Recovery from stool specimens. The stool specimens were streaked onto blood agar plates containing cefoperazonevancomycin-amphotericin (Remel Laboratories). All plates except one were incubated in 5% CO2 at 35°C. One of the isolates was recovered after incubation at 42°C. After 24 h of incubation, colonies appear tiny and pinpoint in size, enlarging to gray and/or white, with entire colonies measuring 2 to 3 mm in diameter after 48 to 72 h of incubation. Presumptive identifications were made by recovery of typical colonies on the selective medium. The detection of a unique sweet, fruity odor and demonstration of negative catalase and cytochrome oxidase reactions by using standard techniques were helpful clues to the identification.
Biochemical identification. Definitive identifications were made by establishing the typical biochemical profile for the following characteristics by using media commercially available (Remel Laboratories), nitrate reduction (nitrate broth with Durham tube), indole production (indole broth), and esculin hydrolysis (esculin agar slant with ferric citrate) and the capability to produce acid from xylose, mannitol, lactose, sucrose, and maltose in fermentation broths with phenol red indicator.
Antimicrobial agent susceptibility testing. Antimicrobial agent susceptibility testing was performed by using the Bauer-Kirby disk diffusion method (8 
RESULTS
Over an 8-month period, we were able to isolate DF-3 from the stool specimens from eight patients ( Table 1) . Three isolates were recovered from 129 different specimens from 78 (2.3%) patients with HIV at the Denver Department of Veterans Affairs Medical Center. Of the 129 specimens from the HIV-infected patients, fifty-three were unformed or liquid and contained two of three DF-3 isolates. Two isolates (1.1%) were recovered from 178 stool samples submitted for C. difficile assays at the Department of Veterans Affairs Medical Center. The remaining three isolates were recovered from routine stool specimens collected as part of a diagnostic work up of diarrhea; two were from the National Jewish Center and one was from the Presbyterian Hospital.
Biochemical profiles. The biochemical profiles for the DF-3 isolates were virtually identical. All strains had the distinctive fruity odor and produced acid fermentatively from xylose, lactose, sucrose, and maltose, except for case 8, which was a slow lactose fermenter, and the strain from case 6, which was lactose negative. All strains were catalase and oxidase negative, none reduced nitrate to nitrite, and none produced acid from mannitol. Six of eight isolates hydrolyzed esculin, and neither of two isolates tested produced indole from tryptophan broth. Antimicrobial agent susceptibility patterns. Except for minor variations, the antimicrobial agent susceptibility profiles were similar for all seven strains ( resistance. Near universal resistance was noted to ampicillin, ampicillin-sulbactam, ceftazidime, cephalothin, ciprofloxacin, and gentamicin. Small zones of inhibition were noted for penicillin and vancomycin. Cell wall fatty acids. Cell wall fatty acid analysis results showed that all strains possessed 12-methyltetradecanoate and all but three of the strains also possessed tetradecanoate and hexadecanoate. There was no correlation between the cell wall fatty acid profiles and clinical symptoms, biochemical characteristics, or antimicrobial agent susceptibility testing.
Endoscopic biopsies. The findings on endoscopic biopsies varied in the four patients examined. Patients 1 and 2 had normal colonic mucosa without inflammation; both patients were receiving corticosteroids at the time of biopsy. A mild chronic inflammatory infiltrate was observed in the lamina propria of patient 7. Biopsy on patient 6 revealed heavily inflamed granulation tissue without normal colonic mucosa being present, which is consistent with underlying chronic ulcerative colitis.
DISCUSSION
The recovery of DF-3 from eight immunocompromised patients (HIV infected, immunosuppressed, or chronic underlying disease) within an 8-month period from patients at three institutions indicates that this organism may be more prevalent than previously suspected. The prevalence in normal hosts is presently unknown. However, we anticipate that DF-3 will be isolated with increasing incidence from immunocompromised patients when selective media are used. The term dysgonic fermenter (indicating poor growth) has been used by the Centers for Disease Control to describe a group of fastidious gram-negative bacilli. Originally named DF-1, this group of organisms was later transferred to the genus Capnocytophaga by Ledbetter et al. (6) . These organisms are typically catalase and oxidase negative and demonstrate a peculiar gliding motility when grown on the surface of blood agar. They have been associated with dental plaque and periodontal infections.
More recently, a second group of dysgonic fermenters, referred to as DF-2, have been found as a cause of septicemia, cellulitis, and endocarditis in patients who had been bitten by or had close contacts with dogs (5, 15) . These organisms have also been placed in the genus Capnocytophaga (C. canimorsus and C. cynodegmO), even though they produce catalase and cytochrome oxidase. The species name for DF- 3 has not yet been designated; however, the biochemical profile is similar to that of the DF-1 organisms.
The key biochemical characteristics of DF-3 include absence of growth on MacConkey and similar enteric isolation media; acid production in the butt of Kligler's and triple sugar iron slants; negative reactions for catalase, oxidase, indole, and nitrate reduction; and a positive reaction for esculin hydrolysis. Fermentation patterns are acid production from glucose, maltose, xylose, lactose, and sucrose but no acid from mannitol. The detection of a distinctly fruity odor produced by colonies growing on agar culture media is also a helpful clue.
Cell wall fatty acid analysis of our eight isolates showed a consistent peak of 12-methyltetradecanoate and lesser amounts of tetradecanoate and hexadecanoate. This is consistent with the findings of Wallace et al. (13) The spectrum of presentations associated with DF-3 in our series of patients ranged from an asymptomatic carrier from whom the organism was spontaneously eliminated to a chronic diarrheal illness showing clinical response to antimicrobial agent treatment. Treated patients had negative follow-up stool cultures for DF-3; however, symptoms did not always clear after elimination of the organism. Four patients with diarrhea had other possible etiologies for their symptoms (B. hominis, Cryptosporidium species, and inflammatory bowel disease).
The group of hosts with altered immunity is rapidly expanding as a result of chemotherapy, transplantation, and more recently as a result of infection with HIV. With appropriate antimicrobial agent therapy DF-3 was relatively easy to eliminate from the patients coinfected with HIV. This contrasts to experience with other organisms such as Campylobacterjejuni which have been difficult to eradicate from stool in the setting of HIV infection in spite of appropriate antimicrobial agent therapy (9) .
Most gastrointestinal pathogens such as the genera Salmonella, Shigella, and Campylobacter require an environmental acquisition in a susceptible host. Other pathogens such as C. difficile can be acquired nosocomially or may require alteration in normal enteric flora only. Still other pathogens such as Cytomegalovirus and Mycobacterium avium complex are associated with impairment of host immunity. Risk factors for acquisition of DF-3 in our patients may have included impairment of immunity due to malignancy, corticosteroid therapy, or coinfection with HIV. In addition, many of our patients also had recently received antimicrobial agents, suppressing the colonization resistance of normal enteric flora. The antimicrobial agents used in these patients, while being broad spectrum, such as ciprofloxacin, metronidazole, and amoxacillin, are agents to which DF-3 shows in vitro resistance. Further reports of asymptomatic carriers of DF-3 will support the possibility that DF-3 is part of normal enteric flora and hence an opportunistic pathogen.
Our experience suggests that by using selective media such as cefoperazone-vancomycin-amphotericin, DF-3 can be recovered in stool from immunocompromised patients. Enteric DF-3 is associated with a wide range of clinical manifestations. Therapy which successfully eliminates the organism from stool cultures is not always associated with resolution of symptoms. Further prospective studies are needed to better define the association of DF-3 with human gastrointestinal disease.
